CN104072407A - 一种Rho激酶抑制剂Y27632化合物的制备方法 - Google Patents
一种Rho激酶抑制剂Y27632化合物的制备方法 Download PDFInfo
- Publication number
- CN104072407A CN104072407A CN201410229820.8A CN201410229820A CN104072407A CN 104072407 A CN104072407 A CN 104072407A CN 201410229820 A CN201410229820 A CN 201410229820A CN 104072407 A CN104072407 A CN 104072407A
- Authority
- CN
- China
- Prior art keywords
- compound
- trans
- added
- ethyl
- add
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- -1 Y27632 compound Chemical class 0.000 title claims abstract description 36
- 238000002360 preparation method Methods 0.000 title claims abstract description 16
- 239000003590 rho kinase inhibitor Substances 0.000 title claims abstract description 16
- 238000006243 chemical reaction Methods 0.000 claims abstract description 54
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 96
- WYURNTSHIVDZCO-UHFFFAOYSA-N tetrahydrofuran Substances C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 52
- 239000000243 solution Substances 0.000 claims description 51
- 150000001875 compounds Chemical class 0.000 claims description 41
- 238000003756 stirring Methods 0.000 claims description 40
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 36
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 36
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 28
- 239000007788 liquid Substances 0.000 claims description 28
- 239000012074 organic phase Substances 0.000 claims description 28
- 239000007787 solid Substances 0.000 claims description 28
- 238000005406 washing Methods 0.000 claims description 26
- NZNMSOFKMUBTKW-UHFFFAOYSA-N Cyclohexanecarboxylic acid Natural products OC(=O)C1CCCCC1 NZNMSOFKMUBTKW-UHFFFAOYSA-N 0.000 claims description 24
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 24
- 239000012141 concentrate Substances 0.000 claims description 20
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 16
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 15
- 238000001914 filtration Methods 0.000 claims description 13
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims description 12
- 150000004702 methyl esters Chemical class 0.000 claims description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N EtOH Substances CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 9
- 229940125898 compound 5 Drugs 0.000 claims description 9
- 238000001035 drying Methods 0.000 claims description 9
- 229910052757 nitrogen Inorganic materials 0.000 claims description 9
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 claims description 8
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 8
- 229910052799 carbon Inorganic materials 0.000 claims description 8
- 239000011259 mixed solution Substances 0.000 claims description 8
- 239000002253 acid Substances 0.000 claims description 7
- 229940125782 compound 2 Drugs 0.000 claims description 7
- 229940126214 compound 3 Drugs 0.000 claims description 7
- 239000000284 extract Substances 0.000 claims description 7
- 229920006395 saturated elastomer Polymers 0.000 claims description 7
- 239000000706 filtrate Substances 0.000 claims description 5
- NWZSZGALRFJKBT-KNIFDHDWSA-N (2s)-2,6-diaminohexanoic acid;(2s)-2-hydroxybutanedioic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O.NCCCC[C@H](N)C(O)=O NWZSZGALRFJKBT-KNIFDHDWSA-N 0.000 claims description 4
- LMDZBCPBFSXMTL-UHFFFAOYSA-N 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide Substances CCN=C=NCCCN(C)C LMDZBCPBFSXMTL-UHFFFAOYSA-N 0.000 claims description 4
- FPQQSJJWHUJYPU-UHFFFAOYSA-N 3-(dimethylamino)propyliminomethylidene-ethylazanium;chloride Chemical compound Cl.CCN=C=NCCCN(C)C FPQQSJJWHUJYPU-UHFFFAOYSA-N 0.000 claims description 4
- NUKYPUAOHBNCPY-UHFFFAOYSA-N 4-aminopyridine Chemical compound NC1=CC=NC=C1 NUKYPUAOHBNCPY-UHFFFAOYSA-N 0.000 claims description 4
- 239000012317 TBTU Substances 0.000 claims description 4
- CLZISMQKJZCZDN-UHFFFAOYSA-N [benzotriazol-1-yloxy(dimethylamino)methylidene]-dimethylazanium Chemical compound C1=CC=C2N(OC(N(C)C)=[N+](C)C)N=NC2=C1 CLZISMQKJZCZDN-UHFFFAOYSA-N 0.000 claims description 4
- 150000008065 acid anhydrides Chemical class 0.000 claims description 4
- 229940125904 compound 1 Drugs 0.000 claims description 4
- 229960000935 dehydrated alcohol Drugs 0.000 claims description 4
- 238000010790 dilution Methods 0.000 claims description 4
- 239000012895 dilution Substances 0.000 claims description 4
- 229960004756 ethanol Drugs 0.000 claims description 4
- LBAQSKZHMLAFHH-UHFFFAOYSA-N ethoxyethane;hydron;chloride Chemical compound Cl.CCOCC LBAQSKZHMLAFHH-UHFFFAOYSA-N 0.000 claims description 4
- 238000000605 extraction Methods 0.000 claims description 4
- 229960004979 fampridine Drugs 0.000 claims description 4
- 239000012065 filter cake Substances 0.000 claims description 4
- IKDUDTNKRLTJSI-UHFFFAOYSA-N hydrazine monohydrate Substances O.NN IKDUDTNKRLTJSI-UHFFFAOYSA-N 0.000 claims description 4
- IHLVCKWPAMTVTG-UHFFFAOYSA-N lithium;carbanide Chemical compound [Li+].[CH3-] IHLVCKWPAMTVTG-UHFFFAOYSA-N 0.000 claims description 4
- 238000002156 mixing Methods 0.000 claims description 4
- VMESOKCXSYNAKD-UHFFFAOYSA-N n,n-dimethylhydroxylamine Chemical compound CN(C)O VMESOKCXSYNAKD-UHFFFAOYSA-N 0.000 claims description 4
- VVWRJUBEIPHGQF-MDZDMXLPSA-N propan-2-yl (ne)-n-propan-2-yloxycarbonyliminocarbamate Chemical compound CC(C)OC(=O)\N=N\C(=O)OC(C)C VVWRJUBEIPHGQF-MDZDMXLPSA-N 0.000 claims description 4
- 238000000746 purification Methods 0.000 claims description 4
- 238000010992 reflux Methods 0.000 claims description 4
- 239000007858 starting material Substances 0.000 claims description 4
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 claims description 4
- 238000010792 warming Methods 0.000 claims description 4
- 125000004494 ethyl ester group Chemical group 0.000 claims description 3
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims description 3
- 238000000034 method Methods 0.000 abstract description 14
- 150000001412 amines Chemical class 0.000 abstract description 5
- 230000015572 biosynthetic process Effects 0.000 abstract description 4
- 230000003287 optical effect Effects 0.000 abstract description 4
- 239000002994 raw material Substances 0.000 abstract description 4
- 238000003786 synthesis reaction Methods 0.000 abstract description 4
- 239000003153 chemical reaction reagent Substances 0.000 abstract description 3
- 238000005750 Corey-Bakshi-Shibata reduction reaction Methods 0.000 abstract description 2
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000004587 chromatography analysis Methods 0.000 description 7
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000005984 hydrogenation reaction Methods 0.000 description 2
- 208000030507 AIDS Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- BHHGXPLMPWCGHP-UHFFFAOYSA-N Phenethylamine Chemical compound NCCC1=CC=CC=C1 BHHGXPLMPWCGHP-UHFFFAOYSA-N 0.000 description 1
- 108091000080 Phosphotransferase Proteins 0.000 description 1
- 102000001253 Protein Kinase Human genes 0.000 description 1
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical class [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- UWTDFICHZKXYAC-UHFFFAOYSA-N boron;oxolane Chemical compound [B].C1CCOC1 UWTDFICHZKXYAC-UHFFFAOYSA-N 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- RPNNPZHFJPXFQS-UHFFFAOYSA-N methane;rhodium Chemical compound C.[Rh] RPNNPZHFJPXFQS-UHFFFAOYSA-N 0.000 description 1
- 102000020233 phosphotransferase Human genes 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 108060006633 protein kinase Proteins 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 229910052703 rhodium Inorganic materials 0.000 description 1
- 239000010948 rhodium Substances 0.000 description 1
- MHOVAHRLVXNVSD-UHFFFAOYSA-N rhodium atom Chemical compound [Rh] MHOVAHRLVXNVSD-UHFFFAOYSA-N 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Abstract
Description
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410229820.8A CN104072407B (zh) | 2014-05-28 | 2014-05-28 | 一种Rho激酶抑制剂Y27632化合物的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410229820.8A CN104072407B (zh) | 2014-05-28 | 2014-05-28 | 一种Rho激酶抑制剂Y27632化合物的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104072407A true CN104072407A (zh) | 2014-10-01 |
CN104072407B CN104072407B (zh) | 2016-01-20 |
Family
ID=51594057
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410229820.8A Active CN104072407B (zh) | 2014-05-28 | 2014-05-28 | 一种Rho激酶抑制剂Y27632化合物的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104072407B (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109280014A (zh) * | 2018-09-05 | 2019-01-29 | 成都百事兴科技实业有限公司 | 反式-4-氨基-环己甲酸乙酯盐酸盐的制备方法 |
CN117285459A (zh) * | 2023-11-24 | 2023-12-26 | 上海美迪西生物医药股份有限公司 | 一种小分子激酶抑制剂化合物的制备方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0370498A2 (en) * | 1988-11-24 | 1990-05-30 | Yoshitomi Pharmaceutical Industries, Ltd. | Trans-4-amino(alkyl)-1-pyridylcarbamoylcyclohexane compounds and pharmaceutical use thereof |
WO2004022541A1 (en) * | 2002-09-03 | 2004-03-18 | Universite De Montreal | 1,4-substituted cyclohexane derivatives |
-
2014
- 2014-05-28 CN CN201410229820.8A patent/CN104072407B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0370498A2 (en) * | 1988-11-24 | 1990-05-30 | Yoshitomi Pharmaceutical Industries, Ltd. | Trans-4-amino(alkyl)-1-pyridylcarbamoylcyclohexane compounds and pharmaceutical use thereof |
WO2004022541A1 (en) * | 2002-09-03 | 2004-03-18 | Universite De Montreal | 1,4-substituted cyclohexane derivatives |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109280014A (zh) * | 2018-09-05 | 2019-01-29 | 成都百事兴科技实业有限公司 | 反式-4-氨基-环己甲酸乙酯盐酸盐的制备方法 |
CN117285459A (zh) * | 2023-11-24 | 2023-12-26 | 上海美迪西生物医药股份有限公司 | 一种小分子激酶抑制剂化合物的制备方法 |
CN117285459B (zh) * | 2023-11-24 | 2024-02-27 | 上海美迪西生物医药股份有限公司 | 一种小分子激酶抑制剂化合物的制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN104072407B (zh) | 2016-01-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Tokuyama et al. | Reduction of ethanethiol esters to aldehydes | |
CN101367757B (zh) | 一种(s)-4-羟基-2-氧代-1-吡咯烷乙酰胺的制备方法 | |
CN104230813B (zh) | 一类peg功能化的双咪唑阳离子温控离子液体及其制备方法和应用 | |
CN104072407B (zh) | 一种Rho激酶抑制剂Y27632化合物的制备方法 | |
CN106146560B (zh) | 一种高纯度磷酸特地唑胺的精制方法 | |
CN103709086A (zh) | 依折麦布光学异构体的制备方法及该方法中使用的中间体 | |
CN104710347B (zh) | (r)‑1‑苄基‑3‑甲基‑1,2,3,6‑四氢哌啶的合成方法 | |
CN106632312B (zh) | 一种阿哌沙班有关物质、中间体、制备方法及其应用 | |
CN104119387B (zh) | 一种米铂的制备方法 | |
CN104193638A (zh) | 一种制备(s)-2`,6`-二甲基酪氨酸及其衍生物的方法及所述衍生物 | |
CN107501196A (zh) | 用于制备地西泮‑d5和地西泮‑d8的中间体及其制备方法 | |
CN103360326A (zh) | 吉非替尼晶型i的精制方法 | |
CN102212075A (zh) | 头孢拉宗的制备方法 | |
CN104610037A (zh) | β-三氟甲基-β-羟基酮的制备方法 | |
CN104529960A (zh) | 一种普芦卡必利中间体的制备方法 | |
CN106349145A (zh) | 一种制备促智药物(s)‑奥拉西坦的方法 | |
CN114195720B (zh) | 一种依托咪酯的纯化方法 | |
CN104876856B (zh) | 一种拆分法制备(r)‑(+)‑3‑氨基哌啶二盐酸盐的方法 | |
CN114057642A (zh) | 一种米库氯铵中间体的合成方法 | |
CN104844495A (zh) | 一种(2s,4s)-4-苯硫基-l-脯氨酸盐酸盐的合成方法 | |
CN107033090B (zh) | 一种1,2,3,4-四氢噌啉的制备方法 | |
CN101973982A (zh) | 一种盐酸法舒地尔的生产方法 | |
CN103539796A (zh) | 一种左旋吡喹酮及其中间体的制备方法 | |
CN103833751B (zh) | 一种长春西汀相关杂质a的合成工艺 | |
CN102731388A (zh) | 一种(r)/(s)-6,6’-二羟基-5,5’-双喹啉的制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20210202 Address after: Room 693, area B, building 20, no.1-42, Lane 83, Hongxiang North Road, Wanxiang Town, Pudong New Area, Shanghai, 200120 Patentee after: Shanghai Yaocheng Medical Technology Co.,Ltd. Address before: 215000 east side of Chang'an Road, Wujiang Economic and Technological Development Zone, Wujiang District, Suzhou City, Jiangsu Province Patentee before: SUZHOU KAIRUI MEDICINE SCIENCE & TECHNOLOGY Co.,Ltd. |
|
CP01 | Change in the name or title of a patent holder | ||
CP01 | Change in the name or title of a patent holder |
Address after: Room 693, area B, building 20, no.1-42, Lane 83, Hongxiang North Road, Wanxiang Town, Pudong New Area, Shanghai, 200120 Patentee after: Dongsheng Kairui (Shanghai) Pharmaceutical Technology Co.,Ltd. Address before: Room 693, area B, building 20, no.1-42, Lane 83, Hongxiang North Road, Wanxiang Town, Pudong New Area, Shanghai, 200120 Patentee before: Shanghai Yaocheng Medical Technology Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20230313 Address after: 730000 Room 218, No. 1346, Daxiahe Street, Lanzhou New Area, Lanzhou City, Gansu Province Patentee after: Lanzhou Yaocheng Pharmaceutical Technology Co.,Ltd. Address before: Room 693, area B, building 20, no.1-42, Lane 83, Hongxiang North Road, Wanxiang Town, Pudong New Area, Shanghai, 200120 Patentee before: Dongsheng Kairui (Shanghai) Pharmaceutical Technology Co.,Ltd. |